Finance

Beta
Lists
STE:NYSE
Steris PLC
USD 208,73
-3,83%
(-8,32) 1D
USD 208,73
0,00% (0,00)
After hours
Closed: 14 Jul., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STE...
Open
USD 214,32
High
USD 214,32
Low
USD 207,68
Mkt. cap
20,34 mjd
Avg. vol.
850,24 k
Volume
0,00
Dividend
1,21%
Quarterly dividend
USD 0,63
Ex-dividend date
08 Jun. 2026
P/E ratio
26,33
52-wk high
USD 269,44
52-wk low
USD 195,14
EPS
USD 7,93
Beta
0,92
Shares outstanding
97,46 m
No. of employees
18 k
Open
USD 214,32
High
USD 214,32
Low
USD 207,68
Mkt. cap
20,34 mjd
Avg. vol.
850,24 k
Volume
0,00
Dividend
1,21%
Quarterly dividend
USD 0,63
Ex-dividend date
08 Jun. 2026
P/E ratio
26,33
52-wk high
USD 269,44
52-wk low
USD 195,14
EPS
USD 7,93
Beta
0,92
Shares outstanding
97,46 m
No. of employees
18 k
News stories
From sources across the web
Profile
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018. Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the President and CEO is Daniel A. Carestio. Wikipedia
About Steris PLC
CEODan Carestio
Employees17,9 k
Founded1985
Headquarters-
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to STE in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for STE in the last 3 months.
Highest
Current USD 208,73
USD 300,00 (+43,73%)
Average
USD 284,50 (+36,30%)
Lowest
USD 269,00 (+28,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brett Fishbin
KeyBanc
Buy
Reiterated
USD 269,00
+28,9%
05/13/2026
Jason Bednar
Piper Sandler
Buy
Maintained
USD 300,00
+43,7%
05/12/2026
Michael Matson
Needham
Hold
Maintained
-
-
05/12/2026
Last report
12 Mei 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
USD 2,83 / USD 2,85
-0,65%miss
Revenue / Est. (USD)
1,59 mjd / 1,60 mjd
-0,45%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
1,39 mjd
1,46 mjd
1,50 mjd
1,59 mjd
Cost of goods sold
763,10 m
815,40 m
841,00 m
890,60 m
Cost of revenue
763,10 m
815,40 m
841,00 m
890,60 m
Research and development expenses
26,40 m
28,20 m
29,50 m
28,80 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
353,30 m
348,40 m
349,00 m
350,70 m
Operating expense
379,70 m
376,60 m
378,50 m
379,50 m
Total operating expenses
1,14 mjd
1,19 mjd
1,22 mjd
1,27 mjd
Operating income
248,30 m
268,30 m
276,70 m
318,30 m
Other non operating income
-
-
-500,00 k
-7,10 m
EBT including unusual items
231,90 m
253,10 m
257,90 m
304,50 m
EBT excluding unusual items
234,10 m
255,80 m
261,30 m
305,90 m
Income tax expense
53,90 m
60,60 m
63,50 m
84,20 m
Effective tax rate
23,24%
23,94%
24,62%
27,65%
Other operating expenses
-
-
-
-
Net income
177,40 m
191,90 m
192,90 m
220,20 m
Net profit margin
12,75%
13,14%
12,89%
13,86%
Earnings per share
2,34
2,47
2,53
2,83
Interest and investment income
1,70 m
2,40 m
-
9,80 m
Interest expense
-15,90 m
-14,90 m
-14,90 m
-15,10 m
Net interest expenses
-14,20 m
-12,50 m
-14,90 m
-5,30 m
Depreciation and amortization charges
-
-
-
-
EBITDA
367,60 m
389,70 m
398,60 m
442,20 m
Gain or loss from assets sale
-
400,00 k
3,20 m
-300,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more